Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Cost-Effectiveness of Nintedanib for Patients with Progressive Fibrosing Interstitial Lung Disease (PF-ILD).
Pharmacoecon Open. 2022 Sep;6(5):647-656. doi: 10.1007/s41669-022-00354-2. Epub 2022 Aug 4.
Pharmacoecon Open. 2022.
PMID: 35927409
Free PMC article.
Budget impact of sequential treatment with first-line afatinib versus first-line osimertinib in non-small-cell lung cancer patients with common EGFR mutations.
Westerink L, Nicolai JLJ, Samuelsen C, Smit HJM, Postmus PE, Griebsch I, Postma MJ.
Westerink L, et al.
Eur J Health Econ. 2020 Aug;21(6):931-943. doi: 10.1007/s10198-020-01186-9. Epub 2020 Apr 23.
Eur J Health Econ. 2020.
PMID: 32328874
Free PMC article.
Item in Clipboard
Trends in NICE technology appraisals of non-small cell lung cancer drugs over the last decade.
Westerink L, Wolters S, Zhou G, Postma A, Boersma C, van Boven JFM, Postma MJ.
Westerink L, et al.
Eur J Health Econ. 2024 Aug 30. doi: 10.1007/s10198-024-01711-0. Online ahead of print.
Eur J Health Econ. 2024.
PMID: 39212880
Item in Clipboard
Tranexamic acid for chronic subdural hematoma.
Lodewijkx R, Immenga S, van den Berg R, Post R, Westerink LG, Nabuurs RJA, Can A, Vandertop WP, Verbaan D.
Lodewijkx R, et al. Among authors: westerink lg.
Br J Neurosurg. 2021 Oct;35(5):564-569. doi: 10.1080/02688697.2021.1918328. Epub 2021 Aug 2.
Br J Neurosurg. 2021.
PMID: 34334070
Item in Clipboard
Cite
Cite